Results 1 to 10 of about 3,980 (50)
Breaking the chains: Advancements in antiviral strategies to combat Nipah virus infections [PDF]
International Journal of One Health, 2023 Nipah virus (NiV) is a highly pathogenic zoonotic virus that has caused several outbreaks with high fatality rates in humans and animals, thus, requiring a “One Health” approach. No specific treatment or vaccine is available for NiV infection, making the
Fredmoore L. Orosco
doaj +1 more source
Journal of Global Antimicrobial Resistance, 2022 : Objectives: As a host restriction factor, apolipoprotein B messenger RNA-editing enzyme catalytic polypeptide-like 3G (APOBEC3G or A3G) has been shown to suppress the replication of several viruses including hepatitis B virus (HBV).
Jin Hu +6 more
doaj +1 more source
Establishment and application of a high-throughput screening model for cell adhesion inhibitors
Frontiers in Pharmacology, 2023 The cell adhesion between leukocytes and endothelial cells plays an important balanced role in the pathophysiological function, while excessive adhesion caused by etiological agents is associated with the occurrence and development of many acute and ...
Han Sun +18 more
doaj +1 more source
Frontiers in Pharmacology, 2021 Nonalcoholic fatty liver disease (NAFLD), especially its advanced stage nonalcoholic steatohepatitis (NASH), has become a threatened public health problem worldwide. However, no specific drug has been approved for clinical use to treat patients with NASH,
Xue-Kai Wang +3 more
doaj +1 more source
Recent Research Progress: Discovery of Anti-Plant Virus Agents Based on Natural Scaffold
Frontiers in Chemistry, 2022 Plant virus diseases, also known as “plant cancers”, cause serious harm to the agriculture of the world and huge economic losses every year. Antiviral agents are one of the most effective ways to control plant virus diseases.
Jixiang Chen +6 more
doaj +1 more source
Frontiers in Microbiology, 2022 We report a quantification of the decrease of effectiveness of antiviral agents directed to hepatitis C virus, when the agents are added during an ongoing infection in cell culture vs. when they are added at the beginning of the infection.
Carlos García-Crespo +21 more
doaj +1 more source
Silver Nanoparticles as Potential Antiviral Agents
Pharmaceutics, 2021 Since the early 1990s, nanotechnology has led to new horizons in nanomedicine, which encompasses all spheres of science including chemistry, material science, biology, and biotechnology.
Zubair Ahmed Ratan +9 more
doaj +1 more source
PLoS ONE, 2023 BackgroundAcute kidney injury is a complication of COVID-19 and is associated with severity. Despite no specific antiviral treatment strategy, lopinavir/ritonavir and remdesivir have been used.
Seyed Majid Mousavi Movahed +8 more
doaj +1 more source
Broad-spectrum antiviral agents
Frontiers in Microbiology, 2015 Development of highly effective, broad-spectrum antiviral agents is the major objective shared by the fields of virology and pharmaceutics. Antiviral drug development has focused on targeting viral entry and replication, as well as modulating cellular ...
Jun-Da eZhu +3 more
doaj +1 more source
Antiviral Agents: Discovery to Resistance
Viruses, 2020 In the midst of the SARS-CoV-2/Covid-19 outbreak the need for research into, and development of, antiviral agents is brought into sharp focus worldwide for scientists, governments and the public alike [...]
Catherine S. Adamson
doaj +1 more source